FDA advisory panel endorses Moderna’s Covid-19 vaccine, clearing way for authorization
An expert panel is meeting Thursday to consider whether the FDA should issue a second emergency use authorization for a Covid-19 vaccine, this one made by Moderna.
Copy and paste this URL into your WordPress site to embed
Copy and paste this code into your site to embed